Xinjian Ji

Xinjian Ji

Auto-generated profile, based on publicly available information

Xinjian Ji

Institute of Chemical Sciences and Engineering, School of Basic Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
XJXinjian Ji
Xinjian Ji
ANAlexander Lund Nielsen
Alexander Lund Nielsen
CHChristian Heinis
Christian Heinis
Cyclic peptides are fascinating molecules abundantly found in nature and exploited as molecular format for drug development as well as other applications, ranging from research tools to food additives. Advances in peptide technologies made over many years through improved methods for synthesis and drug development have resulted in a steady stream of new drugs, with an average of around one cyclic peptide drug approved per year. Powerful technologies for screening random peptide libraries, and de novo generating ligands, have enabled the development of cyclic peptide drugs independent of naturally derived molecules and now offer virtually unlimited development opportunities. In this review, we feature therapeutically relevant cyclic peptides derived from nature and discuss the unique properties of cyclic peptides, the enormous technological advances in peptide ligand development in recent years, and current challenges and opportunities for developing cyclic peptides that address unmet medical needs.

3 July 2015 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
XJXinjian Ji
Xinjian Ji
YLYongzhen Li
Yongzhen Li
WDWei Ding
Wei Ding
Qi ZhangQi Zhang
Qi Zhang

29 September 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
TMTianlu Mo
Tianlu Mo
XJXinjian Ji
Xinjian Ji
WYWei Yuan
Wei Yuan
DMDhanaraju Mandalapu
Dhanaraju Mandalapu
FWFangting Wang
Fangting Wang
Qi ZhangQi Zhang
Qi Zhang

30 August 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
XJXinjian Ji
Xinjian Ji
YLYongzhen Li
Yongzhen Li
LXLiqi Xie
Liqi Xie
HLHaojie Lu
Haojie Lu
WDWei Ding
Wei Ding
Qi ZhangQi Zhang
Qi Zhang

18 March 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
XJXinjian Ji
Xinjian Ji
TMTianlu Mo
Tianlu Mo
WLWan‐Qiu Liu
Wan‐Qiu Liu
WDWei Ding
Wei Ding
ZDZixin Deng
Zixin Deng
Qi ZhangQi Zhang
Qi Zhang

23 October 2023 in Angewandte Chemie
Verified
Journal Article
Open access
XJXinjian Ji
Xinjian Ji
ANAlexander Lund Nielsen
Alexander Lund Nielsen
CHChristian Heinis
Christian Heinis
Cyclic peptides are fascinating molecules abundantly found in nature and exploited as molecular format for drug development as well as other applications, ranging from research tools to food additives. Advances in peptide technologies made over many years through improved methods for synthesis and drug development have resulted in a steady stream of new drugs, with an average of around one cyclic peptide drug approved per year. Powerful technologies for screening random peptide libraries, and de novo generating ligands, have enabled the development of cyclic peptide drugs independent of naturally derived molecules and now offer virtually unlimited development opportunities. In this review, we feature therapeutically relevant cyclic peptides derived from nature and discuss the unique properties of cyclic peptides, the enormous technological advances in peptide ligand development in recent years, and current challenges and opportunities for developing cyclic peptides that address unmet medical needs.